Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005457 |
YEM_ID: | YEM-144 |
ID: | TCMBANKHE005457/YEM-144 |
植物拉丁名: |
|
功能与主治: | To clear heat and dispel damp, expel stone and disinhibit water./Acute nephritis, chronic nephritis, cystitis, urethral stone, rheumatic arthritis. |
药用植物名: | 猫须草|肾茶 |
药名: | 肾茶 |
来源: | 云南民族药物志：第一卷 |
药用部位: | whole herb |
使用民族: | 阿昌族/傣族/德昂族/景颇族/傈僳族 |
TCM_ID_id: | 2052 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000913 | orthosiphols H | ||||
| TCMBANKIN000953 | cleroden E | ||||
| TCMBANKIN001124 | staminols C | ||||
| TCMBANKIN002051 | dihydroconiferyl alcohol | C10H14O3 | 182.22 g/mol | COC1=C(C=CC(C1)C=CCO)O | |
| TCMBANKIN002281 | eupatorin | MolPort-001-742-461; 6-methoxyluteolin-4'',7-dimethyl ether; KBioSS_001517; SCHEMBL555597; EUPATORIN; 3J474AV6MY; Flavone, 3',5-dihydroxy-4',6,7-trimethoxy-; A1-01414; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxychromen-4-one; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-6,7-dimethoxy-chromen-4-one; HMS3262O20; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-; KBio1_001963; MCULE-7438854859; ST50331588; AX8082670; SPBio_000532; KBio2_006653; Kinome_3214; Spectrum4_001833; AC1Q6AIH; ZINC1412; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4-chromenone; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4H-chromen-4-one; AKOS015856247; 3'',5-dihydroxy-4'',6,7-trimethoxy flavone; Flavone, 3',5-dihydroxy-4',6,7-trimethoxy- (8CI); ZB000328; NSC 106402; KBio2_001517; KBio2_004085; Spectrum2_000456; 3',6,7-trimethoxyflavone; KLAOKWJLUQKWIF-UHFFFAOYSA-N; 855-96-9; NSC106402; AC1L3Y1I; 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4h-chromen-4-on; 6-Methoxyluteolin 4',7-dimethyl ether; W1625; Eupatorine; 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4H-1-benzopyran-4-one; 5,3'-Dihydroxy-6,7,4'-trimethoxyflavone; 3,5-dihydroxy-4,6,7-trimethoxyflavone; UNII-3J474AV6MY; DTXSID20234704; ST5331588; LMPK12111239; BDBM50344054; KBioGR_002532; MFCD00016929; FT-0614615; ACon1_001351; I14-111109; TR-026736; AK112334; NCGC00180598-01; 3'',5-DIHYDROXY-4'',6,7-TRIMETHOXYFLAVONE; 6-Methoxyluteolin 4 inverted exclamation marka,7-dimethyl ether; CHEBI:136666; AJ-08019; 4H-1-Benzopyran-4-one, 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy- (9CI); ST24044768; Eupatorin, >=97% (HPLC); ZINC00001412; Eupatorin, analytical standard; CTK8D4716; DivK1c_007019; 4H-1-Benzopyran-4-one,7-dimethoxy-; Flavone,5-dihydroxy-4',6,7-trimethoxy-; NCGC00261484-01; 5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-6,7-dimethoxy-chromone; CHEMBL487402; 4CN-1494; C-57546; SpecPlus_000923; Spectrum_001037; CCG-38698; 3',5-Dihydroxy-4',6,7-trimethoxyflavone; 3 inverted exclamation marka,5-Dihydroxy-4 inverted exclamation marka,6,7-trimethoxyflavone; Tox21_500799; Eupatorin; Spectrum5_000625 | C18H16O7 | 344.3 g/mol | COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)O)O |
| TCMBANKIN002427 | clerospicasins A | ||||
| TCMBANKIN002760 | 2-O-deacetylorthosiphonone A | ||||
| TCMBANKIN006828 | orthosiphols E | ||||
| TCMBANKIN008940 | ethyl3-O-methylrosmarinate | ||||
| TCMBANKIN009592 | Salvigenin | BG01616899; DTXSID90172629; 19103-54-9; 5-Hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one; 5-Hydroxy-6,7,4'-trimethoxyflavone; BDBM50092613; LMPK12111166; 4CN-1814; flavone, 5-hydroxy-4',6,7-trimethoxy-; AKOS032948589; ZINC2561268; 5-Hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one; 7-O-methylpectolinarigenin; 4H-1-Benzopyran-4-one,5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-; SCHEMBL1427018; psathyrotin; QCDYOIZVELGOLZ-UHFFFAOYSA-N; J-012342; AC1L4P44; 4H-1-Benzopyran-4-one, 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-; salvigenin; 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)chromone; 5-hydroxy-4',6,7-trimethoxyflavone; AC1Q6AII; 4H-1-Bbenzopyran-4-one, 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-; MolPort-035-705-973; 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-4-chromenone; CTK4E0570; CHEMBL376644; 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)chromen-4-one; W1622 | C18H16O6 | 328.32 | COC1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)O |
| TCMBANKIN009601 | salvianolic acid H | C27H22O12 | 538.5 g/mol | C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)OC(=CC3=CC(=C(C=C3)O)O)C(=O)O)O)O | |
| TCMBANKIN009724 | neoorthosiphonone A | C38H42O11 | 674.7 g/mol | CC1=CCC(=O)C2(C(CC3C(C(C(C(C3(C2C(=O)C1)C)OC(=O)C4=CC=CC=C4)OC(=O)C)OC(=O)C5=CC=CC=C5)(C)C)OC(=O)C)O | |
| TCMBANKIN010453 | clerospicasins F | ||||
| TCMBANKIN010487 | orthosiphols Q | ||||
| TCMBANKIN011621 | norstamonol B | C39H46O14 | CC(=O)OC1CC2C(C(C(C(C2(C3C1(OC4(C(C3OC(=O)C5=CC=CC=C5)C(CO4)OC(=O)C)C)O)C)OC(=O)C6=CC=CC=C6)OC(=O)C)O)(C)C | ||
| TCMBANKIN011679 | clerospicasins E | ||||
| TCMBANKIN011937 | vinyl caffeate | C11H10O4 | 206.19 g/mol | C=COC(=O)C=CC1=CC(=C(C=C1)O)O | |
| TCMBANKIN014463 | orthosiphols N | ||||
| TCMBANKIN014983 | Dihydrosinapyl alcohol | 4-(3-hydroxypropyl)-2,6-dimethoxyphenol; 4-(3-hydroxypropyl)-2,6-dimethoxy-phenol; 1-Propanol, 3-(4-hydroxy-3,5-dimethoxyphenyl); 20736-25-8; dihydrosinapyl alcohol | C11H16O4 | 212.24 | COC1=CC(=CC(=C1O)OC)CCCO |
| TCMBANKIN016379 | clerospicasins H | ||||
| TCMBANKIN016806 | clerospicasins G | ||||
| TCMBANKIN017661 | neoorthosiphols A | ||||
| TCMBANKIN020266 | 14-deoxo-14-O- acetylorthosiphol Y | 14-deoxo-14-o-acetylorthosiphol y | C26H36O9 | 492.6 g/mol | CC(=O)OC1CC2C(C(=O)C(=CC2(C3C1(C(C(CC3O)(C)C=C)OC(=O)C)O)C)OC(=O)C)(C)C |
| TCMBANKIN020791 | siphonols C | ||||
| TCMBANKIN021532 | ethyl 3,4-dihydroxyphenyllactate | C11H14O5 | 226.23 g/mol | CCC1=C(C=CC(=C1O)O)OC(=O)C(C)O | |
| TCMBANKIN021654 | staminols A | ||||
| TCMBANKIN021945 | methylripario-chromene | C15H18O4 | CC(=O)C1=C(C(=C2C(=C1)C=CC(O2)(C)C)OC)OC | ||
| TCMBANKIN024588 | orthosiphols F | ||||
| TCMBANKIN025389 | orthosiphols I | ||||
| TCMBANKIN026638 | 3'-O-(8″-Z-caffeoyl)rosmarinic acid methyl ester | ||||
| TCMBANKIN028009 | clerospicasins D | ||||
| TCMBANKIN028101 | 1-(3-ethanoxy-4-hydroxyphenyl)-2-hydroxyethanone | ||||
| TCMBANKIN028622 | siphonols A | ||||
| TCMBANKIN029327 | staminolactones B | C38H42O12 | CC(=O)OC1C(C(C2CC(C34C(C2(C1OC(=O)C5=CC=CC=C5)C)C(C(C(O3)(OC4=O)C)C=C)OC(=O)C6=CC=CC=C6)O)(C)C)OC(=O)C | ||
| TCMBANKIN029482 | clerospicasins B | ||||
| TCMBANKIN029563 | orthosiphols G | ||||
| TCMBANKIN029707 | staminolactones A | ||||
| TCMBANKIN029975 | isorinic acid | C18H16O7 | 344.3 g/mol | C1=CC(=CC=C1CC(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O | |
| TCMBANKIN030584 | 6-hydroxysalvonolone | ||||
| TCMBANKIN030655 | clerospicasins C | ||||
| TCMBANKIN031398 | clerospicasins I | ||||
| TCMBANKIN031943 | methylrosmarinate | methyl rosmarinate | C19H18O8 | 374.34 | COC(=O)C(CC1=CC(=C(C=C1)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O |
| TCMBANKIN032277 | siphonols D | ||||
| TCMBANKIN032827 | orthosiphols O | ||||
| TCMBANKIN036790 | rosmarinic acid | (2R)-3-(3,4-dihydroxyphenyl)-2-[3-(3,4-dihydroxyphenyl)acryloyl]oxy-propionic acid; 537-15-5 (ROSMARINATE); (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)-1-oxoprop-2-enoxy]propanoic acid; AIDS-026336; Rosmarimic acid; C10489; ACon1_001068; SMR000445579; 536954_ALDRICH; Benzenepropanoic acid, .alpha.-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-3,4-dihydroxy-, (.alpha.R)-; 20283-92-5 (FREE ACID); (R)-O-(3,4-Dihydroxycinnamoyl)-3-(3,4- dihydroxyphenyl)lactic acid; 20283-92-5; (2R)-3-(3,4-dihydroxyphenyl)-2-[3-(3,4-dihydroxyphenyl)-1-oxoprop-2-enoxy]propanoic acid; MEGxp0_000163; (2R)-3-(3,4-dihydroxyphenyl)-2-[3-(3,4-dihydroxyphenyl)prop-2-enoyloxy]propanoic acid; MLS000697677; 2-[(E)-3-(3,4-dihydroxycyclohexa-1,5-dien-1-yl)-1-hydroxy-allyloxy]-3-(3,4-dihydroxyphenyl)propanoic acid; (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-propanoic acid; SMP1_000245; AIDS026336; 3,4-Dihydroxycinnamic acid (R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethyl ester; Benzenepropanoic acid, .alpha.-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-3,4-dihydroxy-, (R-(E))-; (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)acryloyl]oxy-propionic acid; (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid; Rosmarinic acid | C18H16O8 | 360.315 | c1([H])c([H])c(\C([H])=C([H])\C(=O)O[C@]([H])(C(O[H])=O)C([H])([H])c2c([H])c(O[H])c(O[H])c([H])c2[H])c([H])c(O[H])c1O[H] |
| TCMBANKIN036829 | ursolic acid | ursolicacid; U6753_SIGMA; AIDS-039057; AKOS022168209; Urs-12-en-28-oic acid, 3beta-hydroxy- (8CI); 77-52-1; s2370; 3beta-Hydroxyurs-12-en-28-oic acid; SMR000445681; NSC4060; MLS000728569; Ursolic acid; TOS-BB-0966; 3beta-Hydroxy-12-ursen-28-ic acid; (1S,2R,4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,4a,5,6,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-1H-picene-4-carboxylic acid; ursolic acid ; BSPBio_000018; NSC 167406; H719; 89797_FLUKA; EINECS 201-034-0; Prunol; BPBio1_000020; (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid; AI3-03109; CHEBI:9908; ST056289; Ursolicacid; AC-8029; Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-; Ursolic acid (Malol); CCRIS 7123; BC216337; Urson; (3beta)-3-Hydroxyurs-12-en-28-oic acid; Prestwick3_000089; Malol; C08988; AKOS015965499; SCHEMBL1699371; MolPort-016-633-342; 209545-05-1; AS-13246; AIDS039057; NSC 4060 | C30H48O3 | 456.7 | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C(=O)[O-] |
| TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN037497 | orthosiphol a | C38H44O11 | 676.7 g/mol | CC(=O)OC1CC2C(C(C(C(C2(C3C1(C(=O)C(CC3OC(=O)C4=CC=CC=C4)(C)C=C)O)C)OC(=O)C5=CC=CC=C5)OC(=O)C)O)(C)C | |
| TCMBANKIN038249 | 3-O-Deacetylorthosiphol I | ||||
| TCMBANKIN039196 | Orthosiphonone D | ||||
| TCMBANKIN040154 | orthosiphol d | C31H36O9 | 552.6 g/mol | CC(=O)OC1CC2C(C(=O)C(=CC2(C3C1(C(=O)C(CC3OC(=O)C4=CC=CC=C4)(C)C=C)O)C)OC(=O)C)(C)C | |
| TCMBANKIN040313 | 7-O-Deacetylorthosiphol B | ||||
| TCMBANKIN042022 | Ladanein | 5,6-dihydroxy-7,4'-dimethoxyflavone; 5,6-Dihydroxy-7-methoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one; AC1MJ1UL; 5,6-dihydroxy-4',7-dimethoxyflavone; 4H-1-Benzopyran-4-one, 5,6-dihydroxy-7-methoxy-2-(4-methoxyphenyl)-; 10176-71-3; AKOS032962667; 5,6-dihydroxy-7-methoxy-2-(4-methoxyphenyl)chromen-4-one; UUQJTIHOVGMQIH-UHFFFAOYSA-N; CHEMBL209257; LMPK12111165; ZINC13484812; SCHEMBL737069; DTXSID00144175 | 314.29 g/mol | ||
| TCMBANKIN042924 | Orthosiphol X | 634.7 g/mol | |||
| TCMBANKIN042970 | Orthosiphol M | 570.6 g/mol | |||
| TCMBANKIN043424 | butyl rosmarinate | butylrosmarinate | C22H24O8 | 416.4 g/mol | CCCCOC(=O)C(CC1=CC(=C(C=C1)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O |
| TCMBANKIN043623 | Secoorthosiphol B | 558.6 g/mol | |||
| TCMBANKIN043662 | orthosiphol k | C36H42O10 | 634.7 g/mol | CC(=O)OC1CC2C(C(C(C(C2(C3C1(C(=O)C(CC3OC(=O)C4=CC=CC=C4)(C)C=C)O)C)OC(=O)C5=CC=CC=C5)O)O)(C)C | |
| TCMBANKIN045277 | Staminol A | 734.8 g/mol | |||
| TCMBANKIN046660 | norstaminol a | C37H42O12 | 678.7 g/mol | CC(=O)OC1C(C(C2CC3C4(O3)C(C2(C1OC(=O)C5=CC=CC=C5)C)C(C6C(COC6(O4)C)O)OC(=O)C7=CC=CC=C7)(C)C)OC(=O)C | |
| TCMBANKIN046801 | ethyl rosmarinate | ethylrosmarinate | C19H18O8 | 374.34 | CCOC(=O)C(CC1=CC(=C(C=C1)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O |
| TCMBANKIN047210 | salvianolic acid c | AC1NT063; 3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-(3,4-dihydroxyphenyl)-7-hydroxy-1-benzofuran-4-yl]prop-2-enoyl]oxypropanoic acid; salvianolicacid c | C26H20O10 | 492.43 | C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=C3C=C(OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)O)O |
| TCMBANKIN047566 | Orthosiphonone A | 674.7 g/mol | |||
| TCMBANKIN048307 | orthosiphol b | C38H44O11 | 676.7 g/mol | CC(=O)OC1CC2C(C(C(C(C2(C3C1(C(=O)C(CC3OC(=O)C4=CC=CC=C4)(C)C=C)O)C)OC(=O)C5=CC=CC=C5)O)OC(=O)C)(C)C | |
| TCMBANKIN049084 | 3-Hydroxymegastigm-5-en-9-one | ||||
| TCMBANKIN049299 | lithospermic acid | 54814-35-6; ZINC4097774; SCHEMBL13284084; lithospermicacid; (2S,3S)-2-(3,4-dihydroxyphenyl)-4-[(E)-3-[(1R)-1-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-2-oxoethoxy]-3-oxoprop-1-enyl]-7-hydroxy-2,3-dihydrobenzofuran-3-carboxylic acid; (2S,3S)-2-(3,4-dihydroxyphenyl)-4-[(E)-3-[(1R)-1-[(3,4-dihydroxyphenyl)methyl]-2-hydroxy-2-oxo-ethoxy]-3-oxo-prop-1-enyl]-7-hydroxy-2,3-dihydrobenzofuran-3-carboxylic acid; AK199160; 3-Benzofurancarboxylic acid, 4-(3-(1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxo-1-propenyl)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-; (2S,3S)-2-(3,4-dihydroxyphenyl)-4-[(E)-3-[(2R)-3-(3,4-dihydroxyphenyl)-1-hydroxy-1-oxopropan-2-yl]oxy-3-oxoprop-1-enyl]-7-hydroxy-2,3-dihydro-1-benzofuran-3-carboxylic acid; (2S,3S)-4-[(E)-3-[(1R)-1-(3,4-dihydroxybenzyl)-2-hydroxy-2-keto-ethoxy]-3-keto-prop-1-enyl]-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydrobenzofuran-3-carboxylic acid; MolPort-020-005-934; 28831-65-4; D06ALC; 100IP83JAC; (2S,3S)-2-(3,4-dihydroxyphenyl)-4-[(E)-3-[(2R)-3-(3,4-dihydroxyphenyl)-1-hydroxy-1-oxo-propan-2-yl]oxy-3-oxo-prop-1-enyl]-7-hydroxy-2,3-dihydro-1-benzofuran-3-carboxylic acid; Lithospermic-acid; 11075-67-5; AIDS071478; Lithospermic acid; CHEMBL518243; 3-Benzofurancarboxylicacid,4-[(1E)-3-[(1R)-1-carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxo-1-propen-1-yl]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-,(2S,3S)-; AIDS-071478; 4-(3-(1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy)-3-oxo-1-propenyl)-2-(3,4-dihydroxyphenyl)-2,3-dihydro-7-hydroxy-3-benzofurancarboxylic acid; UNII-100IP83JAC; AC1O5VFB; BDBM50250808; AKOS026674259; 4-{(E)-2-[1-Carboxy-2-(3,4-dihydroxy-phenyl)-ethoxycarbonyl]-vinyl}-2-(3,4-dihydroxy-phenyl)-7-hydroxy-2,3-dihydro-benzofuran-3-carboxylic acid; (2S,3S)-4-[(1E)-3-[(1R)-1-CARBOXY-2-(3,4-DIHYDROXYPHENYL)ETHOXY]-3-OXOPROP-1-EN-1-YL]-2-(3,4-DIHYDROXYPHENYL)-7-HYDROXY-2,3-DIHYDRO-1-BENZOFURAN-3-CARBOXYLIC ACID | C27H22O12 | 538.46 | C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=C3C(C(OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)O)O)O |
| TCMBANKIN049580 | Orthosiphonone C | 528.6 g/mol | |||
| TCMBANKIN050078 | Orthosiphol H | 780.9 g/mol | |||
| TCMBANKIN050336 | 2-O-Deacetylorthosiphol J | ||||
| TCMBANKIN058114 | trans-caffeic acid | 3-(3,4-dihydroxy-phenyl)-acrylic acid; caffeic acid; Caffeate; Lopac-C-0625; 71693-97-5; DivK1c_006624; KBio2_007302; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NCGC00015206-02; CAS-3331-39-5; 60020_FLUKA; AI3-63211; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid polymer; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NSC623438; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; KBio2_004734; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; CHEMBL1320034; AIDS-002287; AIDS002287; 501-16-6; CHEBI:36281; Prestwick1_000902; KBio1_001568; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid; AKOS000273846; OR1165; SMR000058214; Spectrum2_001612; 3,4-dihydroxycinnamate; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeicacid; KOP; AC1NO658; CCRIS 847; Caffeic acid dehydrogenation homopolymer; SPECTRUM1503987; Spectrum4_001694; SCHEMBL3682144; NCGC00017364-01; NCGC00022654-08; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 78734C5A-1281-44D4-B8A0-A3188AD437E3; cis-Caffeic acid; 3-(3,4-dihydroxyphenyl)acrylic acid; Cinnamic acid, 3,4-dihydroxy-; KBioGR_001988; 3,4-Dihydroxybenzeneacrylic acid; 3,4-dihydroxycinnamic acid; trans-caffeic acid; AIDS-026339; NCGC00015206-01; HSDB 7088; ZINC4482687; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3-(3,4-dihydroxyphenyl)prop-2-enoate; Isocaffeic acid; SBB006475; InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2; NCGC00017364-02; EU-0100208; C01197; MolPort-001-759-162; KBioSS_002166; Caffeic acid pure; caffeic acid ; trans-Caffeate; (2E)-3-(3,4-dihydroxyphenyl)acrylic acid; NSC 57197; (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid; Spectrum_001686; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-; KBio2_002166; Caffeic acid, cis-; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-; 3,4-Dihydroxybenzeneacrylate; 3-(3,4-Dihydroxy phenyl)-2-propenoic acid; 4361-87-9; 3,4-Dihydroxy-trans-cinnamate; caffeicacid; AR-360/40806927; EINECS 206-361-2; 60018_FLUKA; Caffeic acid polymer; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; NCGC00022654-04; ZX-AL002121; C0625_SIGMA; SDCCGMLS-0002982.P003; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid, homopolymer; SPBio_001643; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- (9CI); NCGC00017364-03; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid; AC1LU7RL; SPBio_002943; CHEBI:16433; AIDS026339; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, homopolymer; CHEBI:17395; TNP00311; SpecPlus_000528; Prestwick0_000902; MLS000069738; 3,4-dihydroxy-cinnamic acid; 3-(3,4-Dihydroxyphenyl)propenoic acid; NCI60_004400; NSC57197; Caffeic; Lopac-C-0625; NCGC00015206-01; Caffeic acid; cis-Caffeic acid; NCGC00017364-01; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; C01481; 331-39-5; NCGC00015206-02; CAS-3331-39-5; 3,4-Dihydroxycinnamic acid; CHEBI:17395; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; TNP00311; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeate; 1- coffee acid | C9H8O4 | 180.16 g/mol | C1=CC(=C(C=C1C=CC(=O)O)O)O |
| TCMBANKIN058157 | salvianic acid a;danshensu | MolPort-027-836-277; W-203757; DS-182; SCHEMBL18469325; AN-8468; CHEBI:71572; KS-00000R2J; UNII-NA8H56YM3K component PAFLSMZLRSPALU-MRVPVSSYSA-N; ACN-035342; AKOS006328573; 3,4-dihydroxyphenyllactic acid; Danshensu; (2R)-3-(3,4-dihydroxyphenyl)-2-hydroxypropanoic acid; AK119798; HY-N1913; SC-96866; (2R)-3-(3,4-dihydroxyphenyl)-2-hydroxy-propanoic acid; Benzenepropanoic acid, alpha,3,4-trihydroxy-, (alphaR)-; AC-7985; AJ-24202; Salianic acid A; BC251342; Salvianic acid A; (R)-3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoic acid; BG01512207; s4741; (2R)-3-(3,4-dihydroxyphenyl)lactic acid; I14-53224; MFCD09038703; DTXSID60469215; FCH869720; FT-0696736; (2R)-3-(3,4-dihydroxyphenyl)-2-hydroxy-propionic acid; ZINC895535; Dan shen suan A; 76822-21-4; CS-5614; danshensu ; r-(+)-beta-(3,4-dihydroxyphenyl)-lactic acid; UNII-4GF33A5PAJ; 4GF33A5PAJ | C9H10O5 | 198.17 g/mol | C1=CC(=C(C=C1CC(C(=O)O)O)O)O |
| TCMBANKIN058322 | baicalein | 5,6,7-trihydroxyflavanone; KBio3_002435; NCGC00025282-03; 5,6,7-trihydroxy-2-phenyl-chromen-4-one; AIDS-000731; 5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one; baicalein ; Sho-saiko-to; 5,6,7-trihydroxy-2-phenylchromen-4-one; ST057152; Spectrum_000427; SPECTRUM1504002; 5,6,7-trihydroxy-2-phenyl-chromone; KBio1_001798; KBio2_006043; NSC 661431; 11712_FLUKA; SDCCGMLS-0066744.P001; KBioSS_000907; CHEBI:2979; SMP1_000037; 5,6,7-trihydroxy-2-phenyl-4-chromenone; LMPK12140610; SPBio_000572; NCGC00025282-02; Dihydrobaicalein; Baicalein; 5,6,7-trihydroxy-2-phenyl-chroman-4-one; Spectrum4_000537; KBioGR_001173; 491-67-8; NCGC00017236-01; S00113; 465119_ALDRICH; Spectrum5_001418; Oprea1_765614; Tocris-1761; DivK1c_006854; NSC729192; AIDS000731; BSPBio_003215; SCHEMBL12068882; 5,6,7-Trihydroxyflavone; Spectrum3_001608; KBio2_003475; SpecPlus_000758; 5,6,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one; NSC661431; NCGC00025282-01; 5,6,7-trihydroxy-2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one; C10023; Spectrum2_000466; TNP00121; KBio2_000907; ZINC00017881; Biacalein; 5,6,7-trihy-droxyflavone | C15H10O5 | 270.24 g/mol | C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)O)O |
| TCMBANKIN058987 | staminol b | C38H44O12 | 692.7 g/mol | CC(=O)OC1C(C(C2CC(C3(C(C2(C1OC(=O)C4=CC=CC=C4)C)C(C(C(C3=O)(C)O)C=C)OC(=O)C5=CC=CC=C5)O)O)(C)C)OC(=O)C | |
| TCMBANKIN058988 | siphonol b | siphonols B | C38H44O12 | 692.7 g/mol | CC(=O)OC1C(C(C2CC(C3(C(C2(C1OC(=O)C4=CC=CC=C4)CO)C(CC(C3=O)(C)C=C)OC(=O)C5=CC=CC=C5)O)O)(C)C)OC(=O)C |
| TCMBANKIN059014 | staminol d | staminols D | C31H36O10 | 568.6 g/mol | CC(=O)OC1CC2C(C(=O)C(=CC2(C3C1(C(=O)C(C(C3OC(=O)C4=CC=CC=C4)C=C)(C)O)O)C)OC(=O)C)(C)C |
| TCMBANKIN059015 | neoorthosiphol b | neoorthosiphols B | C38H44O12 | 692.7 g/mol | CC(=O)OC1CC2C(C(C(C(C2(C3C1(C(=O)C(C(C3OC(=O)C4=CC=CC=C4)C=C)(C)O)O)C)OC(=O)C5=CC=CC=C5)O)OC(=O)C)(C)C |
| TCMBANKIN059016 | siphonols E | siphonol e | C39H44O14 | 736.8 g/mol | CC(=O)OC1CC2C(C(C(C(C2(C3C1(C(=O)C(CC3OC(=O)C4=CC=CC=C4)(C)C=O)O)CO)OC(=O)C5=CC=CC=C5)OC(=O)C)OC(=O)C)(C)C |
| TCMBANKIN061249 | caffeic acid ethyl ester | C11H12O4 | 208.21 g/mol | CCOC(=O)C=CC1=CC(=C(C=C1)O)O | |
| TCMBANKIN061351 | Insularine | insularine; UNII-60I96OKL0W; O-Methylinsulanoline; 60I96OKL0W; 549-07-5; 6,9-(Epoxymethano)-8,11:20,23-dietheno-1H,12H-(1,10)dioxacyclooctadecino(2,3,4-ij:11,12,13-i'j')diisoquinoline, 2,3,12a,13,14,15,24,24a-octahydro-5,17,18-trimethoxy-1,13-dimethyl-, (12aR,24aR)-; Insularine [MI] | C38H40N2O6 | 620.7 g/mol | CN1CCC2=CC(=C3C4=C2C1CC5=CC=C(C=C5)OC6=C7C(CC8=CC(=C(O4)C=C8)CO3)N(CCC7=CC(=C6OC)OC)C)OC |
| TCMBANKIN061394 | Methyl caffeate | 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, methyl ester, (2E)-; N79173B9HF; 3-(3,4-dihydroxyphenyl)acrylic acid methyl ester; (E)-3-(3,4-dihydroxyphenyl)acrylic acid methyl ester; BG01510488; STK523948; Caffeic acid methyl ester; Caffeic acid methyl; C10477; methyl (E)-3-(3,4-dihydroxyphenyl)-2-propenoate; AX8139367; CHEMBL17001; AKOS003263230; Methyl 1-(3'',4''-dihydroxyphenyl)propenate; ACM3843741; methyl 3-(3,4-dihydroxyphenyl)acrylate; caffeic acid methylester; Caffeic acid, methyl ester; J-502041; AK131257; ST5306988; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid methyl ester; BG01510487; FCH5604426; AC1Q5YZ9; RL04585; ZX-AN022874; methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate; ST094769; Methyl 1-(3',4'-Dihydroxyphenyl)Propenate; ZINC00058222; (E)-methyl-3-(3,4-dihydroxyphenyl)acrylate; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, methyl ester, (E)-; API0016257; AC1LENEX; KB-02534; Methyl 3,4-dihydroxycinnamate; SBB000325; AJ-09841; 3,4-dihydroxycinnamic acid methyl ester; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid methyl ester; AX8252180; AIDS-085228; SC-88492; TC-133588; METHYLCAFFEATE; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, methyl ester; (E)-3-(3,4-Dihydroxy-phenyl)-acrylic acid methyl ester; ZB002356; 3-(3,4-Dihydroxy-phenyl)-acrylic acid methyl ester; (E)-3-(3,4-Dihydroxyphenyl)propenoic Acid Methyl Ester; KB-255969; 4978AB; ST24031000; (E)-methyl 3-(3,4-dihydroxyphenyl)acrylate; BDBM50029209; methyl caffeate; BBV-44220535; 3843-74-1; R2609; CHEBI:6856; AIDS085228; OCNYGKNIVPVPPX-HWKANZROSA-N; AC1Q5YKG; (E)-3-(3,4-dihydroxyphenyl)-2-propenoic acid methyl ester; ALBB-024360; UNII-N79173B9HF; ZINC58222; Methylcaffeate; 67667-67-8; methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate; MCULE-5269580490; C-1420; methyl (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate; MolPort-002-747-457; methyl (2E)-3-(3,4-dihydroxyphenyl)acrylate; (E)-Methyl3-(3,4-dihydroxyphenyl)acrylate; AK-88791; A4212/0179337; MFCD00210468; methyl (E)-3-[3,4-bis(oxidanyl)phenyl]prop-2-enoate; A824271 | C10H10O4 | 194.18 g/mol | COC(=O)C=CC1=CC(=C(C=C1)O)O |
| TCMBANKIN061487 | 5,6,7,3,4-pentamethoxyflavone | Sinensetin; API0004181; Pedalitin permethyl ether; SR-05000002257-3; A816546; BC282855; KB-221448; 5,6,7,3',4'-Pentamethoxyflavone; 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxy-4-chromenone; Flavone, 5,6,7,3',4'-pentamethoxy; AKOS016009570; N2560; 240LNZ51AT; 2-(3,4-Dimethoxyphenyl)-5,6,7-trimethoxy-4H-chromen-4-one #; CS-5907; FT-0634191; DTXSID60177626; ST24039240; C10186; NCGC00163623-01; SR-05000002257; 3'',4'',5,6,7-pentamethoxy flavone; sinensetin; CCG-208419; CHEMBL226507; AN-50682; DB-046067; C-57750; 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxy-chromen-4-one; HY-N0297; 27181-91-5; 2-(3,4-Dimethoxyphenyl)-5,6,7-trimethoxy-4H-chromen-4-one; MEGxp0_000957; CHEBI:9159; CJ-24105; ZINC1531698; ST5331679; X1234; UNII-240LNZ51AT; SR-05000002257-2; BRD-K84996949-001-01-5; 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxy-4H-1-benzopyran-4-one; MolPort-001-741-112; 3',4',5,6,7-Pentamethoxyflavone; VA11761; BDBM50338975; AJ-26732; MFCD00017421; AK111262; 306S276; KB-221449; 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxy-1-benzopyran-4-one; LKMNXYDUQXAUCZ-UHFFFAOYSA-N; 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxychromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxy-; AC1L3RN3; 2306-27-6; 5,6,7,3'',4'' -pentamethoxyflavone; SCHEMBL621101; LMPK12111250; TR-010778; 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxy-chromone; CTK4F9237; ST50331679 | C20H20O7 | 372.37 | COC1=C(C=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC)OC)OC)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab